Silverarc Capital Management’s Mineralys Therapeutics MLYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.56M	Sell	115,282 -223,072	-66%	-$3.02M	0.29%	44
2025 Q1	$5.37M	Buy	+338,354	New	+$5.37M	1.1%	26
2024 Q2	–	Sell	-56,944	Closed	-$735K	–	76
2024 Q1	$735K	Buy	+56,944	New	+$735K	0.2%	64